01177.HK
Sino Biopharmaceutical Limited
HKSE · Healthcare · Biotechnology · HK
HKD 5.47
−0.45%Next report
Analyst consensus
- Next report date
- Apr 1, 2027
- EPS estimate
- HKD 0.11
- Revenue estimate
- HKD 19.6B
Latest reported
- Last report date
- Aug 19, 2026
- EPS actual
- HKD 0.22
- EPS estimate
- HKD 0.14
- Revenue actual
- HKD 22.4B
- Revenue estimate
- HKD 22.3B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +58.6%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 19, 2026 | HKD 0.14 | HKD 0.22 | Beat 58.56% | HKD 22.4B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Apr 1, 2027